| 6/21/2007 |
The Wall Street Journal Health Blog
Pharma Box Office: Novartis Blankets Blood Pressure |
| 6/19/2007 |
Reuters.com
Glaxo’s U.S. Avandia decline starts to stabilize |
| 6/13/2007 |
The Philadelphia Inquirer
Amid Avandia doubts, diabetics consider alternatives |
| 5/21/2007 |
The Wall Street Journal Health Blog
Pharma Box Office: Diabetes Drugs |
| 4/5/2007 |
The Wall Street Journal Health Blog
Pharma Box Office: Sales Force Shifts |
| 3/20/2007 |
Deutsche Bank Securities, Inc. and ImpactRx, Inc.- Webinar Presentation |
| 1/11/2007 |
Star Ledger
Pfizer vs Pfizer |
| 1/4/2007 |
Star Ledger
GSK fights back |
| 12/21/2006 |
Star Ledger
Zyprexa’s trouble |
| 12/14/2006 |
Star Ledger
A strong start |
| 12/7/2006 |
Star Ledger
The battle for physician’s attention |
| 11/29/2006 |
Star Ledger
Rep Numbers |
| 11/29/2006 |
The Wall Street Journal
Who’s News |
| 11/29/2006 |
The Philadelphia Inquirer
Drug market-research firm names new CEO |
| 11/9/2006 |
Star Ledger
Januvia in the Spotlight |
| 9/28/2006 |
Star Ledger
Winning the Popularity Contest |
| 9/14/2006 |
Star Ledger
Making a Comeback |
| 6/15/2006 |
Star Ledger
Dueling diabetes treatments |
| 6/8/2006 |
Star Ledger
Consistency of the salesman |
| 6/1/2006 |
Star Ledger
Putting the hurt on the competition |
| 5/25/2006 |
Star Ledger
New drug on the block |
| 5/15/2006 |
Star Ledger
To warn or not to warn |
| 5/14/2006 |
Star Ledger
Battle for the Cholesterol Market |
| 5/11/2006 |
Star Ledger
Fosamax fights back |
